Dr Vismay Deshani – Manchester
Future UK Haematology Service Model: Integration of Specialist Centres, District Hospitals, Community Care, and Workforce Innovation by 2040

Dr Kirsty Sharplin – Oxford
Haematology’s brave new world: from gene editing to intelligent care

Dr Josh Coats – Dundee
Transforming lymphoma: liquid biopsy, novel molecular sub-classification, and precision risk-adapted treatment with frontline targeted therapeutics

Dr Venetia D’Arcy – Cambridge
Predictive, preventive and patient-centred: a 15-year vision for acute myeloid leukaemia management

Dr Joseph Frogatt – Manchester
Genomics and personalised therapy: the future of haematology through a clinical trials lens

Dr Catherine Lecat – London
How will artificial intelligence transform haematology care?

Dr Adrian Maraj – London
Artificial intelligence-driven platforms will transform integrated diagnostics and cell therapy delivery across haematological malignancies in the UK

Dr Lorna Neill – Bristol
The future of haematology – AI advances, targeted treatments, increasing immunotherapy amid substantial strains

Dr Keir Pickard – Newcastle
Personalised medicine in lymphoma; from pipe dream to reality

Dr Gavinda Sangha – Cambridge
Advances in haematology care in the coming decade

Dr Dipal Mehta – London
Transforming haematology through data and discovery: lessons from myeloma

Dr Jennifer Vidler – London
Personalised haematology in the age of multi-omics and artificial intelligence

Dr Ravindu de Silva – Norwich
From detection to cure: the future of personalised immunotherapy in lymphoma

Dr Ryan Low – London
From hospitals to homes: a vision for AI-enabled haematology in 2040

Dr Charlotte Brierley – Oxford
Haematology in 2040: an overview of how genomic and digital innovations will redefine diagnosis, treatment, and prevention